Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Universal Starch Chem Allied Ltd

UNIVSTAR
BSE
147.50
2.15%
Last Updated:
30 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Universal Starch Chem Allied Ltd

UNIVSTAR
BSE
147.50
2.15%
30 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
62Cr
Close
Close Price
147.50
Industry
Industry
Starch
PE
Price To Earnings
9.62
PS
Price To Sales
0.13
Revenue
Revenue
474Cr
Rev Gr TTM
Revenue Growth TTM
-4.70%
PAT Gr TTM
PAT Growth TTM
35.65%
Peer Comparison
How does UNIVSTAR stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
UNIVSTAR
VS

Quarterly Results

Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
1391361201261451339112913812197118
Growth YoY
Revenue Growth YoY%
5.90.00.43.94.4-2.0-24.11.8-4.8-8.96.8-8.5
Expenses
ExpensesCr
1341291161241381289611813012093108
Operating Profit
Operating ProfitCr
574275-51082510
OPM
OPM%
3.84.93.41.55.14.0-5.78.25.61.34.78.3
Other Income
Other IncomeCr
101020001010
Interest Expense
Interest ExpenseCr
222222223222
Depreciation
DepreciationCr
111211222222
PBT
PBTCr
341-162-974-216
Tax
TaxCr
100011001001
PAT
PATCr
241-141-873-315
Growth YoY
PAT Growth YoY%
-46.5158.4406.7-158.785.1-66.0-1,181.6816.3-34.4-271.9109.3-25.4
NPM
NPM%
1.73.20.6-0.83.11.1-9.05.52.1-2.10.84.5
EPS
EPS
5.810.21.8-2.310.73.5-19.616.77.0-6.01.812.5

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
196165214198279264296456516527491474
Growth
Revenue Growth%
6.2-15.529.6-7.641.0-5.412.354.013.02.2-6.9-3.4
Expenses
ExpensesCr
190163215190268254279431498507473451
Operating Profit
Operating ProfitCr
62-181110182617201824
OPM
OPM%
3.01.3-0.33.84.13.85.95.63.43.83.75.0
Other Income
Other IncomeCr
233122123322
Interest Expense
Interest ExpenseCr
544467787899
Depreciation
DepreciationCr
544445445667
PBT
PBTCr
-2-4-61307168949
Tax
TaxCr
-1-2-2120142212
PAT
PATCr
-1-2-40116116736
Growth
PAT Growth%
-129.0-55.1-148.8105.9468.8-53.3862.279.8-48.418.4-54.0100.2
NPM
NPM%
-0.6-1.0-2.00.10.50.32.12.51.11.30.71.4
EPS
EPS
-2.6-4.0-10.00.63.41.615.127.214.116.67.715.3

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
444444444444
Reserves
ReservesCr
64993234374854626664
Current Liabilities
Current LiabilitiesCr
5160735872828083101116116112
Non Current Liabilities
Non Current LiabilitiesCr
292520334037555245414036
Total Liabilities
Total LiabilitiesCr
9094106104149157175187204224226216
Current Assets
Current AssetsCr
4248505158708381941109993
Non Current Assets
Non Current AssetsCr
48455553918792106110114126123
Total Assets
Total AssetsCr
9094106104149157175187204224226216

Cash Flow

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
17-413-811111134-11923
Investing Cash Flow
Investing Cash FlowCr
-5-2-2-1-18-1-9-18-9-9-18
Financing Cash Flow
Financing Cash FlowCr
-93-11810-111-1814-10-5
Net Cash Flow
Net Cash FlowCr
3-3002-13-24-10
Free Cash Flow
Free Cash FlowCr
12-611-9-810216-9104
CFO To PAT
CFO To PAT%
-1,514.2240.9-318.6-3,033.0789.01,601.2168.2300.9-14.7272.1703.1
CFO To EBITDA
CFO To EBITDA%
284.9-190.0-1,962.6-100.797.5106.461.1134.7-5.094.5123.0

Ratios

Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
12012122082958457665
Price To Earnings
Price To Earnings
0.00.00.047.514.012.44.55.17.710.920.4
Price To Sales
Price To Sales
0.10.00.10.10.10.00.10.10.10.10.1
Price To Book
Price To Book
1.20.00.90.90.50.20.71.10.81.10.9
EV To EBITDA
EV To EBITDA
5.813.6-50.46.25.75.04.53.96.06.67.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
16.715.212.216.616.816.923.321.617.819.619.4
OPM
OPM%
3.01.3-0.33.84.13.85.95.63.43.83.7
NPM
NPM%
-0.6-1.0-2.00.10.50.32.12.51.11.30.7
ROCE
ROCE%
8.41.0-5.59.010.78.815.024.112.213.39.8
ROE
ROE%
-10.8-20.0-32.31.83.91.715.521.910.110.54.6
ROA
ROA%
-1.2-1.8-4.00.20.90.43.66.12.93.11.4
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Universal Starch Chem Allied Limited is a premier Indian maize refiner with a legacy spanning over **52 years**. The company operates a vertically integrated manufacturing model, transforming raw maize into a sophisticated portfolio of starches, sweeteners, and industrial derivatives. Serving as a critical supplier to the **Pharmaceutical, Food, Textile, and Paper** industries, the company is currently transitioning from a traditional commodity processor to a high-value derivatives manufacturer with an expanding global footprint. --- ### **Core Manufacturing Infrastructure & Vertical Integration** The company’s operations are centralized at its primary integrated facility in **Dhule District, Maharashtra**, which has undergone significant scaling since inception. * **Processing Capacity:** The facility has expanded from an initial **60 MTS** to a current refining capacity of **750 MTS per day**. * **Strategic Asset Acquisition:** Under the **SARFAESI Act**, the company recently acquired land, buildings, and machinery for **₹17.18 Crores**. This strategic move is designed to facilitate the production of high-value derivatives and expand the existing product line. * **Sustainability & Captive Power:** To mitigate energy costs and environmental impact, the company operates: * A **Co-Generation Power Plant** utilizing bio-gas from an **Effluent Treatment Plant**. * A **Wind Mill** located at **Brahmanwel** for renewable energy generation. * A **Biomethanation Project** and a **Fly Ash Brick Making Project** for waste valorization. * **Quality & Compliance:** The facility holds a **GMP license** from the **FDA (MS)**. Recent upgrades include a new **Air Handling Unit (AHU)** at the Microbiology Laboratory to ensure strict adherence to mandatory FDA hygiene and safety standards. --- ### **Diversified Product Portfolio & Market Applications** The company reports under a single business segment (**Maize Products**) as per **Ind AS-108**, yet maintains a highly diversified output categorized by industrial application: | Category | Key Products | Primary Industrial Use | | :--- | :--- | :--- | | **Primary Starches** | Maize Starch Powder, Modified Starch | Food thickening, Paper coating, Textile sizing | | **Specialized Derivatives** | **White Dextrin**, **Pregelatinized Starch** | Adhesives, Industrial binders | | **Sweeteners & Syrups** | **Liquid Glucose**, **Dextrose Syrup**, **Dextrose Monohydrate**, **Dextrose Anhydrous** | Confectionery, Pharmaceutical excipients, Beverages | | **Nutritional By-Products** | **Maize Gluten**, Maize Germ, Maize Husk | High-protein animal and poultry feed | The company has been recognized as a **'Best Vendor'** by the **OPPI** for its role as a reliable excipient supplier to the pharmaceutical sector. --- ### **Financial Performance & Growth Metrics** While the company has demonstrated long-term resilience, recent fiscal cycles reflect the volatility of the agricultural commodity market. | Metric (Rs. in Lacs) | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | :--- | | **Total Sales & Other Income** | **49,089.13** | **53,023.00** | **51,872.00** | | **Profit Before Depreciation** | **1,055.70** | **1,501.00** | **1,319.00** | | **Net Profit Before Tax (PBT)** | **427.28** | **922.00** | **810.00** | **Performance Analysis:** * **Revenue Trends:** Following a peak in FY 2023-24, sales contracted by **7.14%** in the most recent period due to adverse market conditions. * **Profitability:** Operating profit and PBT saw a decline in the latest cycle, attributed to volatile raw material pricing and shifting demand. * **Incentives:** The company is eligible for a **₹73.45 crore incentive** under the **Package Scheme of Incentive - 2007**, which provides a steady cash inflow of **₹7.34 crore per year** over a **10-year** period. --- ### **Strategic Roadmap: Expansion & R&D** The company’s growth strategy is centered on **organic expansion** and moving up the value chain. * **Export Market Penetration:** A primary strategic pillar is increasing the share of exports, with a specific focus on the **Middle East** market to diversify revenue streams. * **R&D Focus:** The dedicated **Research & Development Department** is tasked with upgrading production technology for **Value-Added Products** and refining **Standard Operating Procedures (SOP)** to drive energy savings and productivity. * **Agricultural Outlook:** Management anticipates a **30% increase** in local maize cultivation over the next two years as farmers shift from competing crops, which is expected to stabilize raw material costs. * **Cost Optimization:** Implementation of stringent cost-cutting measures is underway to protect margins against inflationary pressures. --- ### **Governance, Leadership & Capital Structure** The company is led by the promoter family with a restructured board to oversee its next growth phase. * **Key Leadership:** * **Chairman & MD:** Mr. Jitendrasinh J. Rawal (Term: **3 years** from Oct 2024). * **Joint MD:** Mr. Jaykumar J. Rawal (Term: **3 years** from Aug 2023). * **CFO:** Mr. Jivan Mali (Appointed Nov 2024). * **Board Composition:** **10 members**, including **5 Independent Directors**, ensuring balanced oversight through Audit and Stakeholder committees. * **Financing Strategy:** To avoid high institutional interest rates, the company secured an unsecured loan of **₹4.25 crores** from the Managing Director. Shareholders have approved a resolution allowing the **conversion of these loans into equity** in the event of a repayment default, priced according to **SEBI regulations**. --- ### **Risk Factors & Mitigation** Investors should note the following risks inherent in the company’s operating environment: * **Commodity Volatility:** As maize is the primary feedstock, the company is exposed to monsoon risks and price fluctuations. This is reflected in **Inventory Valuation**, where the **Net Realizable Value (NRV)** of finished goods is treated as a **Key Audit Matter** (Finished goods value rose from **₹5.22 crore** in 2024 to **₹11.08 crore** in 2025). * **Regulatory Compliance:** * **Labour Codes:** New labour codes introduced in **November 2025** resulted in an exceptional financial impact of **₹5.40 lakhs** due to revised gratuity definitions. * **SEBI LODR:** The company is working toward **100% Dematerialization** of promoter holdings and addressing a **₹38,000 fine** from the BSE regarding director age-limit resolutions. * **Legal Constraints:** Domestic growth in certain **modified starch** segments is currently limited by Indian legal restrictions on specific applications. * **Competitive Landscape:** Rising demand for maize in the **bio-energy** sector is increasing competition for raw materials, necessitating the company's focus on geographic diversification.